Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence

PURPOSE: To reduce false-negative rates (FNR) in sentinel lymph node biopsy (SLNB) of clinically positive (cN+) axilla in patients undergoing neoadjuvant chemotherapy (NAC). The removal of three or more lymph nodes with dual-tracer mapping including a radioisotope was used. However, in the Brazilian...

Descripción completa

Detalles Bibliográficos
Autores principales: Resende, Heloisa Magda, Lichtenfels, Martina, Soares, Igor Camargo, Renó, Angélica Araújo Cortines Laxe, Cunha, Ana Paula, Falcão, Pedro Gustavo, Pieroni, Carolina Soares Pimentel, de Assis, Biazi Ricieri, Cardoso, Paola, Marassi, Pedro Henrique Adário, Reis, Rafael dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253600/
https://www.ncbi.nlm.nih.gov/pubmed/34231654
http://dx.doi.org/10.1590/ACB360608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253600/
https://www.ncbi.nlm.nih.gov/pubmed/34231654
http://dx.doi.org/10.1590/ACB360608

Ejemplares similares